Novistra Capital advises Percos, a leading Dermatology focused pharmaceutical company, for the sale of its Vedaderm brand to Cipla
New Delhi, October 2015
Novistra Capital, a New York based global financial services firm, announced today that Percos India Pvt. Ltd., one of India’s leading dermatology focused skin-care company, has sold its Vedaderm brand of cosmeceutical and chemical peel products to Cipla, India’s third largest drug-maker.

Percos India, founded by one of India’s top Dermatologists, Dr. V. K. Upadhyaya, is one of India’s leading dermatology focused skin care company with its head office in New Delhi, India. Percos, over the years, has developed a strong brand in the doctor-prescribed and medical aesthetics dermatology market by developing a strong portfolio of products for treatment of skin disorders such as psoriasis, acne, wrinkles, aging of the skin, hyper-pigmentation and more.

Cipla is India’s third largest drug-maker that is engaged in the business of manufacturing, processing, promotion, marketing, sale and distribution of medicinal and pharmaceutical preparations of various kinds and nature for varying ailments and disorders. The Company is based out of Mumbai, India.